Delivery Order SPE2DB22D1202-SPE2DB24FURB6
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY vaccine syringes (0.3mL) for recipients aged 12 and up. The $3,735.75 order has a completion date of February 5, 2024 and was awarded on February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this delivery order which is not set aside. The company also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,800.76 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and above, with a completion date of September 10, 2024. The award is not a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $2,009.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COMIRNATY (COVID-19 vaccine) syringes for individuals 12 years and older, with a period of performance through April 18, 2024. This is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,019,775 units of the COMIRNATY vaccine (0.3 mL syringe) for individuals aged 12 and above. The contract has a ceiling value of $5,359.92 and a performance period through March 21, 2024. This delivery order is placed under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY 2023-24 (12 and up) syringes (0.3 mL). The $2,009.97 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a $14,670 firm fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4565938767 COMIRNATY 2024-25(12Y UP) syringes in 0.3ML. This order is part of a larger Indefinite Delivery Contract between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COMIRNATY (Pfizer-BioNTech COVID-19 Vaccine) syringes for individuals 12 years of age and older. The contract has a potential value of $2,434.48 and a performance period through February 26, 2024. This order does not have a set-aside designation and was issued under Amerisourcebergen Drug Corp's existing indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,667.50 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of COMIRNATY (COVID-19) vaccine syringes in 0.3mL doses for individuals 12 years and older. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA to provide a comprehensive range of...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $1,607.48, is for the delivery of COMIRNATY (COVID-19 vaccine) syringes for individuals aged 12 and older. This is a firm fixed-price Delivery Order contract with a completion date of April 30, 2024. The contract does not have a set-aside designation....
- This is a $7,402.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COMIRNATY 2024-25 (12 years and up) syringes (0.3 mL) and has an ultimate completion date of January 15, 2025. This contract is not associated with any set-aside designation. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FURB6Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,241.45 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the supply of COMIRNATY 2023-24 (12Y UP) SYRG 0.3ML vaccine syringes. This delivery order contract is associated with a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 2/20/24 |